Objective To investigate the current situation of randomized controlled trials or clinical controlled trial (RCT/CCT) on chronic hepatitis B and whether to offer reliable evidence for clinical practice in China.
Methods RCT/CCT identified from six Chinese clinical journals were searched manually and assessed according to international standard of evidence-based medicine.
Results 308 issues containing 212 therapeutic articles and 88 RCT/CCT on chronic hepatitis B were identified and analyzed.
Conclusion the quantity and quality of RCT/CCT of chronic hepatitis B did not meet the need of clinical practice.
Citation： GUO Zhen,WANG Yiping,JIN ShuIi,ZHAO Pengcheng. Analysis of therapeutic articles on chronic hepatitis B in China. Chinese Journal of Evidence-Based Medicine, 2002, 02(2): 101-103. doi: Copy